thiazolidinediones (TZDs). These drugs bind to receptors in the fat cells, making them more sensitive to insulin and thereby amplifying insulin’s effects. So TZDs such as rosiglitazone, sold under the brand name Avandia, and pioglitazone, sold as Actos, lower blood glucose but do not raise insulin levels; instead, they help the body use the available insulin more effectively.
